KR-20260065457-A - NON ALCHOL WHIKEY COMPRISING GABA

Abstract

The present invention relates to whisky containing GABA, and specifically provides whisky containing GABA that has the effect of regulating nerve excitability and inhibiting the proliferation of diabetes and cancer cells.

Inventors

• 조영민

Assignees

• 조영민

Dates

Publication Date

20260508

Application Date

20250106

Priority Date

20241101

Claims (4)

1. Fermented grain liquid; GABA extracted from kimchi; and natural sweeteners; including Non-alcoholic whiskey.
2. In paragraph 1, The above grain fermentation liquid is Fermented by inoculating with Bacillus subtilis, Non-alcoholic whiskey.
3. In paragraph 1, 70 mass% to 90 mass% of grain fermentation liquid; GABA 5% to 20% by mass; and Non-alcoholic whiskey containing 0.1 mass% to 0.5 mass% of a natural sweetener.
4. In paragraph 1, The above natural sweetener is monk fruit juice, Non-alcoholic whiskey.

Description

Non-alcoholic whiskey containing GABA The present invention relates to a non-alcoholic whiskey containing GABA. Whiskey is a representative distilled and aged spirit originating from Northern Scotland or Ireland. It is a type of alcohol made by fermenting and distilling grains such as malt, barley, corn, wheat, and oats. Recently, with the rising popularity of highballs (mixed with sparkling water) in Korea, the demand for whiskey has been surging. Meanwhile, as drinking culture shifts toward a healthy culture of enjoying alcohol, there is a growing trend of avoiding intoxication while still appreciating the taste, carbonation, and refreshing sensation of the alcohol itself, leading to a significant increase in demand for non-alcoholic beverages. Non-alcoholic beverages are classified into alcohol-free (which contains no alcohol at all) and non-alcoholic (which contains less than 1% alcohol). Under Korea's Liquor Tax Act, beverages with an alcohol content of less than 1% are classified as beverages, while those with 1% or more are classified as alcoholic beverages. Conventional non-alcoholic beverages undergo a long-term distillation process to remove alcohol from fermented grains or fruits. However, this distillation process alters the unique taste or aroma of the grains or fruits, resulting in a significant decline in sensory quality. Consequently, additives such as spices and sweeteners are used to improve sensory quality, but these additives contain chemical components harmful to the human body, posing a problem of adverse effects on consumer health. Meanwhile, GABA (Gamma-AminoButyric Acid) is a type of non-protein amino acid and a neurotransmitter. GABA is a neurotransmitter associated with various psychiatric and neurological disorders, including anxiety, pain, depression, insomnia, and epilepsy, and plays a crucial role in regulating neuronal excitability throughout the nervous system. Additionally, GABA possesses hypotensive, sedative, diuretic, and anti-diabetic effects, regulates serum lipid levels, and inhibits the proliferation of cancer cells. Due to these beneficial effects of GABA, interest in it is increasing not only as a pharmaceutical but also as a food ingredient. Although GABA is found in legumes, grains, teas, and seaweed, its content is very low, making it difficult to obtain through food artificially. Due to this limitation, research is actively underway to extract GABA with high yields and to discover and utilize food ingredients with increased GABA content. In this specification, singular expressions include plural expressions unless the context clearly indicates otherwise. In this specification, the terms “comprise” and/or “comprising” specify the presence of the mentioned features, steps, numbers, actions, parts, elements, and/or groups thereof, and do not exclude the presence or addition of one or more other features, steps, numbers, actions, parts, elements, and/or groups thereof. In this specification, expressions such as "first," "second," "first," "second," "(S1)," "(S2)," etc. may modify various components regardless of order and/or importance, and do not limit such components. These expressions may be used to distinguish one component from another. For example, without departing from the scope of the present disclosure, the first component may be named the second component, and similarly, the second component may be renamed the first component. In this specification, "at least one of a, b and c" is defined as one or more selected from the group consisting of a, b and c. Where various embodiments are described in this specification, each embodiment may be combined unless specifically stated otherwise. In this case, the effects of the present invention may be defined as including effects derived from each embodiment and effects resulting from the organic combination of each embodiment. For example, even if embodiments 1 and 2 are described independently in this specification, unless the context clearly indicates otherwise, embodiments 1 and 2 may be organically combined with each other, and the effects of the present invention may include effects resulting from the combination of embodiments 1 and 2. In this specification, a range of numerical values indicated by the term 'to' represents a range of numerical values that includes the values listed before and after the term as the lower and upper limits, respectively. For example, if 'a to b' is described in the specification, it may be understood that 'a to b' (a to b) is described. In the present specification, if multiple numerical values are disclosed for the upper and lower limits of any numerical range, the numerical range disclosed in the present specification may be understood as a range of any numerical values in which any one of the multiple lower limit values and any one of the multiple upper limit values are respectively the lower limit value and the upper limit value. For example, if a or greater, or b or greater